Mandatory Notification of TB Diagnosis
ContentTB is a notifiable disease in India, and TB notification has been made mandatory at the point of diagnosis since May 2012. This means that when a case of TB is diagnosed and/or put on treatment it is to be reported to the NTEP.
- Every healthcare provider, i.e., clinical establishments run or managed by the Government (including local authorities), private or NGO sectors and/or individual practitioners, need to notify diagnosed or treated TB patient’s.
- Reporting is to be done on the online reporting system called Nikshay and should include details of patient identification, and TB diagnosis.
- This, apart from enabling essential public health actions such as Treatment initiation, and Contact Tracing, chemoprophylaxis, but also enables provisions of Direct beneficiary transfer for Nikshay Poshan Yojana
Points to Note:
As per MCI code of ethics a registered medical practitioner giving incorrect information on his name and authority about notification amounts to misconduct and such a medical practitioner is liable for deregistration. It is the duty of the registered medical to divulge this information to the authorized notification official as regards communicable and notifiable diseases.
Resources
Nikshay
ContentNikshay is an Integrated ICT system for TB patient management and care in India. Nikshay was launched in 2012 and since then, various improvements have been made in the system.
Nikshay provides-
- A Unified interface for public and private sector health care providers
- Different types of Logins such as State, District, TU, PHI, Staff logins, Private providers, Chemist, Labs and PPSA/JEET Logins
- Integration of all adherence technologies such as 99DOTS and MERM
- Unified DSTB and DRTB data entry forms
- Mobile friendly website with mobile app
Nikshay is accessible either via web browser(https://Nikshay.in ) or mobile App called ‘Nikshay’ that can be downloaded from Google Play Store(Android).
Figure: Nikshay Login Pages
TB Case classification in NTEP
ContentTB cases are generally classified on the basis of previous history of TB treatment into New and previously treated cases.
New case - A TB patient who has never had treatment for TB or has taken anti-TB drugs for less than one month is considered as a new case.
Previously treated patients have received 1 month or more of anti-TB drugs in the past. They could be further classified as:
- Recurrent TB case - A TB patient previously declared as successfully treated (cured/treatment completed) and is subsequently found to be microbiologically confirmed TB case is a recurrent TB case.
- Treatment After failure patients are those who have previously been treated for TB and whose treatment failed at the end of their most recent course of treatment.
- Treatment after loss to follow-up - A TB patient previously treated for TB for 1 month or more and was declared lost to follow-up in their most recent course of treatment and subsequently found microbiologically confirmed TB case
- Other previously treated patients are those who have previously been treated for TB but whose outcome after their most recent course of treatment is unknown or undocumented.
Resources:
Kindly provide your valuable feedback on the page to the link provided HERE
Continuum of TB Care
ContentWhat is the "continuum of TB Care"?
Tuberculosis in contrast to other infectious diseases affects humans over a long period of time. Stages such as uninfected, infected, and disease, do not have clearly demarcated time points and stages blend with each other when a person is converting or transitioning from one to the other. In addition, a person cured from TB may get re-infected and diseased, or still harbor a few dormant TB bacteria which may get reactivated at some future time; this too needs to be cared for. Hence, TB care is visualized as a continuous spectrum of care, with parts that requires varying type and intensity of services throughout a person's lifecycle, called the continuum of care.
Continuum of TB care is a concept that emphasizes that care provision/ TB related health care services exists is in a continuum for an individual's lifetime. It includes services before and after the current episode of TB including vulnerable population, TB infection, post treatment follow-up and recurrence of TB.
NOTE:
- When interacting with a person it is important to locate the person in this continuum of care. This is done by a combination of screening for TB disease, testing for TB infection, asking for the previous history of TB/ checking for existing records in Nikshay using patient identifiers.
- In alignment with the continuum of care concept, Nikshay follows a lifecycle approach. It is able to document and track a patient throughout the continuum using any of the Patient ID or Episode ID or any of the service identifiers(Test ID, Transfer ID etc).
Resources
- Guidelines for Programmatic Management of Tuberculosis Preventive Treatment in India.
- Standards for TB Care in India.
Assessment
Question Answer 1 Answer 2 Answer 3 Answer 4 Correct answer Correct explanation Page id Part of Pre-test Part of Post-test Continuum of care involves a life cycle based approach toward delivering healthcare services for TB. True False 1 Continuum of care means that delivery of services under NTEP is in a continuum for an individual's lifetime and extends beyond the current episode of TB. Symptoms of TB Disease
ContentActive TB disease has 4 major symptoms (the 4 Symptom complex). Presence of any one of these symptoms without any other reason warrants evaluation for TB. These are:

Figure: Signs and Symptoms of TB
People affected with TB may experience other symptoms as well. These may be based on the site that is affected with TB or other more non-specific symptoms of an infection. The physician or doctor would evaluate these symptoms in view of diagnosis of TB.
Resources:
Screening For Tuberculosis Disease
ContentScreening for active tuberculosis (TB) a process to filter out people who are less likely to have TB, from a group. Screened positive people are likely to have TB and are confirmed subsequently using a TB diagnostic test. This will allow finite diagnostic testing resources to be used on the remaining.
Screening in TB may be performed using simple field tools (4 Symptom complex) and tests such as Chest X-ray, or a combination of both. Combination of both is the most effective, but is often not applied due to the practical difficulties in making a chest X-ray conveniently available.
Screening is an integral part of any general case finding effort. It is also applied systematically in specific situations.
- At health care facilities (intensified case finding): Here those visiting are screened using the 4 symptom complex, often at the point of entry to the facility. Those screened positive may be fast-tracked to TB Diagnostic testing.
- In vulnerable populations in active case finding efforts: Here the entire population identified for active case finding are screened using the pre-decided protocols by going door to door.
Resources
Testing for TB diagnosis
ContentNational Tuberculosis Elimination Programme (NTEP) strives for all presumptive TB patients to be microbiologically confirmed. Under NTEP, the acceptable methods for microbiological diagnosis of TB are:
Sputum Smear Microscopy (for Acid Fast Bacilli - AFB): Sputum Smear microscopy is the primary tool which is reliable, inexpensive, easily accessible and rapid method of diagnosing PTB, where in the bacilli are demonstrated in the sputum. Two types:
-
Ziehl-Neelsen Staining
-
Fluorescence staining
Rapid diagnostic molecular test: Rapid molecular tests that use techniques like NAAT are very specific. They amplify the genomic material in the patient sample and hence enhances detection
-
Nucleic Acid Amplification Test (NAAT) e.g., GeneXpert, TrueNat
Figure: Genxpert Machine for CBNAAT
Figure: Truenat Machine
- Line Probe Assay
Culture and DST: A culture test involves studying bacteria by growing the bacteria on different substances. This is to find out if particular bacteria are present. In the case of the TB culture test, the test is to see if the TB bacteria Mycobacterium tuberculosis, are present.
Two types:
-
Solid (Lowenstein Jensen) media
-
Liquid media (Middlebrook) e.g., Bactec MGIT etc.
-
Fullscreen